FDG PET/CT for the diagnosis in rectal cancer

FDG PET/CT for the diagnosis in rectal cancer - FDG PET/CT for rectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041653

Enrollment

100

Registered

2020-09-05

Start date

2017-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pathologically proven rectal cancer

Exclusion criteria

Exclusion criteria: Uncontrolled diabetes Not adenocarcinoma

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy for tumor stating	—

Secondary

Measure	Time frame
The efficacy for predicting prognosis	—

Countries

Japan

Contacts

Public ContactMasatoshi Hotta

National Center for Global Health and Medicine Nuclear Medicine

mhotta@hosp.ncgm.go.jp03-3202-7181

Outcome results